to assess safety and efficacy of neoadjuvant radiochemotherapy with docetaxel and cisplatin for esophageal carcinom
SummaryBackgroundTrimodality therapy with surgery and neoadjuvant chemoradiotherapy (nCRT) has been ...
Background: This multicenter phase II study investigated the efficacy and feasibility of preoperativ...
textabstractThis study was performed to assess the efficacy and safety of preoperative chemoradiatio...
Background: A phase II trial to evaluate neoadjuvant (NAD), surgery and adjuvant (AD) combination ch...
A phase I trial of concurrent chemoradiotherapy with non-split administration of docetaxel and cispl...
Objective: Definitive chemoradiotherapy is one of the curative options for resectable esopha-geal sq...
Objective: Definitive chemoradiotherapy is one of the curative options for resectable esopha-geal sq...
Contains fulltext : 70883.pdf (publisher's version ) (Open Access)ABSTRACT: BACKGR...
IntroductionBased on favorable preliminary clinical data and the need to identify effective, well-to...
Background: Trimodality therapy with surgery and neoadjuvant chemoradiotherapy (nCRT) has been devel...
İstanbul Bilim Üniversitesi, Tıp Fakültesi.PURPOSE: Concomitant use of chemotherapy and a radiation...
Contains fulltext : 200332.pdf (publisher's version ) (Open Access)BACKGROUND: Nea...
Background: A phase II trial to evaluate neoadjuvant (NAD), surgery and adjuvant (AD) combination ch...
Background: This phase I/II-trial assessed the dose-limiting toxicities (DLT) and maximum tolerated ...
Objective: Neoadjuvant chemoradiotherapy improves survival in patients with locoregional esophageal ...
SummaryBackgroundTrimodality therapy with surgery and neoadjuvant chemoradiotherapy (nCRT) has been ...
Background: This multicenter phase II study investigated the efficacy and feasibility of preoperativ...
textabstractThis study was performed to assess the efficacy and safety of preoperative chemoradiatio...
Background: A phase II trial to evaluate neoadjuvant (NAD), surgery and adjuvant (AD) combination ch...
A phase I trial of concurrent chemoradiotherapy with non-split administration of docetaxel and cispl...
Objective: Definitive chemoradiotherapy is one of the curative options for resectable esopha-geal sq...
Objective: Definitive chemoradiotherapy is one of the curative options for resectable esopha-geal sq...
Contains fulltext : 70883.pdf (publisher's version ) (Open Access)ABSTRACT: BACKGR...
IntroductionBased on favorable preliminary clinical data and the need to identify effective, well-to...
Background: Trimodality therapy with surgery and neoadjuvant chemoradiotherapy (nCRT) has been devel...
İstanbul Bilim Üniversitesi, Tıp Fakültesi.PURPOSE: Concomitant use of chemotherapy and a radiation...
Contains fulltext : 200332.pdf (publisher's version ) (Open Access)BACKGROUND: Nea...
Background: A phase II trial to evaluate neoadjuvant (NAD), surgery and adjuvant (AD) combination ch...
Background: This phase I/II-trial assessed the dose-limiting toxicities (DLT) and maximum tolerated ...
Objective: Neoadjuvant chemoradiotherapy improves survival in patients with locoregional esophageal ...
SummaryBackgroundTrimodality therapy with surgery and neoadjuvant chemoradiotherapy (nCRT) has been ...
Background: This multicenter phase II study investigated the efficacy and feasibility of preoperativ...
textabstractThis study was performed to assess the efficacy and safety of preoperative chemoradiatio...